Stocks
Inovio Pharmaceuticals, Inc.INO
NASDAQHealthcareBiotechnology$1.66-1.19%
Price as of · delayed, not real-time
Focused on developing DNA-based immunotherapies and vaccines, this biotech firm targets cancers and infectious diseases. Investors monitor its clinical-stage pipeline, particularly its COVID-19 vaccine candidate that faced regulatory hurdles. The company's low market cap reflects its speculative profile as a pre-revenue biotech play.
Market Cap: $89.0M52W Range: $1.30 – $2.98
Congressional Interest in Inovio Pharmaceuticals, Inc. (INO)
4 members of Congress have disclosed 4 trades in Inovio Pharmaceuticals, Inc. (INO), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 2 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
4
Buys
2
Sells
2
Who in Congress Is Trading INO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-09-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2018-06-25 | Chris Collins | buy | $15K – $50K |
| 2017-04-03 | JOHN ABNEY CULBERSON | buy | $1K – $15K |
| 2017-03-04 | Kurt Schrader | sell | $1K – $15K |